ATE403665T1 - Verfahren und zusammensetzungen zur modulierung der gluconeogenese mit pgc-1 - Google Patents
Verfahren und zusammensetzungen zur modulierung der gluconeogenese mit pgc-1Info
- Publication number
- ATE403665T1 ATE403665T1 AT02720906T AT02720906T ATE403665T1 AT E403665 T1 ATE403665 T1 AT E403665T1 AT 02720906 T AT02720906 T AT 02720906T AT 02720906 T AT02720906 T AT 02720906T AT E403665 T1 ATE403665 T1 AT E403665T1
- Authority
- AT
- Austria
- Prior art keywords
- pgc
- methods
- gluconeogenesis
- compositions
- modulating
- Prior art date
Links
- 102000017946 PGC-1 Human genes 0.000 title abstract 5
- 108700038399 PGC-1 Proteins 0.000 title abstract 5
- 230000004110 gluconeogenesis Effects 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 230000001594 aberrant effect Effects 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26676501P | 2001-02-05 | 2001-02-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE403665T1 true ATE403665T1 (de) | 2008-08-15 |
Family
ID=23015907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02720906T ATE403665T1 (de) | 2001-02-05 | 2002-02-05 | Verfahren und zusammensetzungen zur modulierung der gluconeogenese mit pgc-1 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20030045470A1 (de) |
| EP (1) | EP1366059B1 (de) |
| JP (1) | JP2004526436A (de) |
| AT (1) | ATE403665T1 (de) |
| AU (1) | AU2002251873A1 (de) |
| CA (1) | CA2437727A1 (de) |
| DE (1) | DE60228056D1 (de) |
| WO (1) | WO2002062297A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7947652B2 (en) | 2004-09-03 | 2011-05-24 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for modulating PGC-1α to treat huntington's disease |
| FI20041540A0 (fi) * | 2004-11-29 | 2004-11-29 | Markku Laakso | Menetelmä diabetesta hoitavien yhdisteiden seulomiseksi |
| US7763441B2 (en) | 2006-03-13 | 2010-07-27 | Wyeth | Modulators of gluconeogenesis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6426411B1 (en) * | 1997-05-30 | 2002-07-30 | Dana-Farber Cancer Institute | PGC-1, a novel brown fat pparγ coactivator |
| WO1998054220A1 (en) * | 1997-05-30 | 1998-12-03 | Dana-Farber Cancer Institute | PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR |
-
2002
- 2002-02-05 AT AT02720906T patent/ATE403665T1/de not_active IP Right Cessation
- 2002-02-05 AU AU2002251873A patent/AU2002251873A1/en not_active Abandoned
- 2002-02-05 CA CA002437727A patent/CA2437727A1/en not_active Abandoned
- 2002-02-05 US US10/066,443 patent/US20030045470A1/en not_active Abandoned
- 2002-02-05 DE DE60228056T patent/DE60228056D1/de not_active Expired - Fee Related
- 2002-02-05 JP JP2002562305A patent/JP2004526436A/ja active Pending
- 2002-02-05 WO PCT/US2002/003240 patent/WO2002062297A2/en not_active Ceased
- 2002-02-05 EP EP02720906A patent/EP1366059B1/de not_active Expired - Lifetime
-
2005
- 2005-01-06 US US11/031,450 patent/US7371529B2/en not_active Expired - Fee Related
-
2007
- 2007-12-21 US US11/963,152 patent/US20080248475A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1366059A4 (de) | 2004-03-31 |
| WO2002062297A2 (en) | 2002-08-15 |
| US20080248475A1 (en) | 2008-10-09 |
| EP1366059B1 (de) | 2008-08-06 |
| US7371529B2 (en) | 2008-05-13 |
| WO2002062297A9 (en) | 2002-12-12 |
| US20030045470A1 (en) | 2003-03-06 |
| CA2437727A1 (en) | 2002-08-15 |
| EP1366059A2 (de) | 2003-12-03 |
| WO2002062297A3 (en) | 2002-10-03 |
| US20050234001A1 (en) | 2005-10-20 |
| AU2002251873A1 (en) | 2002-08-19 |
| DE60228056D1 (de) | 2008-09-18 |
| JP2004526436A (ja) | 2004-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60237917D1 (de) | Gfats als modifikatoren des p53-wegs und verwendungsverfahren | |
| MY146548A (en) | Certain chemicals entities, compositions, and methods | |
| ATE437184T1 (de) | Varianten der fc-region | |
| WO2005020921A3 (en) | C-kit modulators and methods of use | |
| DK2392565T3 (da) | c-Met-modulatorer og anvendelsesfremgangsmåder | |
| ATE380029T1 (de) | Prodrugs von gaba-analoga, zusammensetzungen und ihre verwendungszwecke | |
| EP1613348A4 (de) | Verfahren zur modulierung der angiogenese mit apelin-zusammensetzungen | |
| CY1110555T1 (el) | 4-((φαινοξυαλκυλ)θειο)-φαινοξυοξεικα οξεα και αναλογα | |
| WO2005037232A3 (en) | Methods and compositions for modulating adipocyte function | |
| ATE428413T1 (de) | Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen | |
| WO2005028678A3 (en) | Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby | |
| ATE504836T1 (de) | Verfahren zur identifizierung von trpv2- modulatoren | |
| WO2007094755A3 (en) | Compositions and methods for modulating cognitive function | |
| DE60326248D1 (de) | Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen | |
| ATE302002T1 (de) | Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit | |
| ATE354802T1 (de) | Methoden zum screening knochenmorphogenetishemimetika | |
| DE60140074D1 (de) | Non-apoptotische formen des zelltods und verfahren zur modulation | |
| DE60228056D1 (de) | Verfahren und zusammensetzungen zur modulierung der gluconeogenese mit pgc-1 | |
| DK1506313T3 (da) | Fremgangsmåder til screening af modulatorer af den mitokondrielle NAD-afhængige deacetylase SIRT3 | |
| DE60325695D1 (de) | Der eaat2-promotor und dessen verwendung | |
| TW200741009A (en) | Methods of modulating SMYD3 for treatment of cancer | |
| DE69943374D1 (de) | Verfahren zur modulation der angiogenese mittels der tyrosin kinase src | |
| DE60217651D1 (de) | Zur modulation der krebszellenproliferation geeignetes polynukleotid | |
| IL203968A0 (en) | Photodamage modulator for treating uv photodamage | |
| ATE328904T1 (de) | Modulation der tetraspanin funktion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |